XGN
Exagen Inc
NASDAQ: XGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.76
+1.10% today
Updated 2026-04-29
Market cap
$65.91M
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$3 – $12
Volume
0.3M
Exagen Inc (XGN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-34.5%
Last 4 quarters
Revenue YoY growth
+21.8%
Most recent quarter
EPS YoY growth
-33.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-12.7%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-23 | $-0.27 | -48.8% | $2.78 | $2.74 | -1.4% |
| 2025-11-04 | $-0.31 | -93.8% | $11.83 | $10.33 | -12.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.18 | $-0.27 | -48.8% | $16.63M | +21.8% |
| 2025-09-30 | $-0.16 | $-0.31 | -93.8% | $17.24M | +37.9% |
| 2025-06-30 | $-0.15 | $-0.21 | -40.0% | $17.20M | +14.2% |
| 2025-03-31 | $-0.36 | $-0.20 | +44.4% | $15.50M | +7.5% |
| 2024-12-31 | $-0.24 | $-0.20 | +16.7% | $13.65M | -0.8% |
| 2024-09-30 | $-0.29 | $-0.28 | +5.0% | $12.51M | -6.8% |
| 2024-06-30 | $-0.34 | $-0.16 | +52.9% | $15.06M | +6.6% |
| 2024-03-31 | $-0.36 | $-0.19 | +47.2% | $14.41M | +28.4% |
| 2023-12-31 | $-0.43 | $-0.31 | +27.9% | $13.77M | — |
| 2023-09-30 | $-0.47 | $-0.31 | +34.0% | $13.42M | — |
| 2023-06-30 | $-0.49 | $-0.28 | +42.9% | $14.14M | — |
| 2023-03-31 | $-0.56 | $-0.44 | +21.4% | $11.23M | — |
| 2022-12-31 | $-0.78 | $-0.83 | -6.4% | — | — |
Frequently asked questions
Has Exagen Inc beaten earnings estimates?
Exagen Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -34.5% over the last 4 quarters.
How does XGN stock react to earnings?
XGN stock has moved an average of -7.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Exagen Inc's revenue growth rate?
Exagen Inc reported year-over-year revenue growth of +21.8% in its most recent quarter, with EPS growing -33.1% year-over-year.